Abedaziz M Ahmed

Learn More
Chemotherapy with praziquantel (PZQ) is the mainstay of schistosomiasis control. However, there are recent concerns about tolerance or resistance to PZQ, so that monitoring its efficacy in different settings is required. A longitudinal study was conducted to evaluate the impact of PZQ for the treatment of Schistosoma haematobium infection among(More)
  • 1